AU2749395A - Medical use of bromelain - Google Patents

Medical use of bromelain

Info

Publication number
AU2749395A
AU2749395A AU27493/95A AU2749395A AU2749395A AU 2749395 A AU2749395 A AU 2749395A AU 27493/95 A AU27493/95 A AU 27493/95A AU 2749395 A AU2749395 A AU 2749395A AU 2749395 A AU2749395 A AU 2749395A
Authority
AU
Australia
Prior art keywords
bromelain
medical use
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27493/95A
Inventor
Christian Engwerda
Tracey Leahanne Mynott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortecs Ltd
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of AU2749395A publication Critical patent/AU2749395A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU27493/95A 1994-06-24 1995-06-26 Medical use of bromelain Abandoned AU2749395A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9412711A GB9412711D0 (en) 1994-06-24 1994-06-24 Medical use of bromelain
GB9412711 1994-06-24
PCT/GB1995/001501 WO1996000082A1 (en) 1994-06-24 1995-06-26 Medical use of bromelain

Publications (1)

Publication Number Publication Date
AU2749395A true AU2749395A (en) 1996-01-19

Family

ID=10757263

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27493/95A Abandoned AU2749395A (en) 1994-06-24 1995-06-26 Medical use of bromelain

Country Status (13)

Country Link
EP (1) EP0766565A1 (en)
JP (1) JPH10502073A (en)
KR (1) KR970703784A (en)
CN (1) CN1151119A (en)
AU (1) AU2749395A (en)
CA (1) CA2193654A1 (en)
FI (1) FI965204A (en)
GB (1) GB9412711D0 (en)
IL (1) IL114331A0 (en)
NO (1) NO965564L (en)
TW (1) TW403654B (en)
WO (1) WO1996000082A1 (en)
ZA (1) ZA955292B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9526691D0 (en) * 1995-12-29 1996-02-28 Cortecs Ltd Medical use of proteases
JP2001513636A (en) 1997-02-25 2001-09-04 コルテクス（ユーケイ）リミティッド Bromelain ingredients
ES2288762T3 (en) * 1997-02-25 2008-01-16 Sarantis Pty Ltd BROMELINE COMPONENT
US20020102253A1 (en) * 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
NO304766B1 (en) 1997-06-16 1999-02-08 Sintef fingerprint Sensor
DE19726255C2 (en) * 1997-06-20 2000-03-16 Mucos Pharma Gmbh & Co Influence of cytokines by proteolytic enzymes and rutoside
DE19726244C2 (en) * 1997-06-20 2000-03-02 Mucos Pharma Gmbh & Co Use of proteolytic enzymes and rutoside to prevent or treat graft rejection
DE19726254C2 (en) * 1997-06-20 1999-10-21 Mucos Pharma Gmbh & Co Tolerance induction through proteases
GB9713667D0 (en) * 1997-06-27 1997-09-03 Cortecs Ltd Enhancement of intestinal permeability
GB9819138D0 (en) * 1998-09-02 1998-10-28 Cortecs Uk Ltd Nucleic acids and proteins from pineapple stem
GB9819137D0 (en) * 1998-09-02 1998-10-28 Cortecs Uk Ltd Component of bromelain
DE19847114A1 (en) * 1998-10-13 2000-04-20 Mucos Pharma Gmbh & Co Use of proteolytic enzymes to modulate hyperactive T cells, especially for symptomatic treatment of immune-mediated inflammatory diseases, e.g. multiple sclerosis, diabetes, arthritis or glomerulonephritis
CA2346448A1 (en) * 1998-12-16 2000-06-22 Warner-Lambert Company Treatment of arthritis with mek inhibitors
DE19957318A1 (en) * 1999-11-29 2001-06-21 Mucos Pharma Gmbh & Co Influence of TGF-beta by proteolytic enzymes
DE10018980A1 (en) * 2000-04-17 2001-11-08 Mucos Pharma Gmbh & Co Prophylaxis and therapy of diabetes mellitus I using proteolytic enzymes
EP1208849B1 (en) 2000-11-28 2015-10-28 URSAPHARM Arzneimittel GmbH Use of bromelain for adjuvant therapy during wound healing process
TW201419131A (en) 2012-11-09 2014-05-16 Health & Life Co Ltd Voice-assisted biomedical sensing apparatus
US9526768B2 (en) * 2014-11-13 2016-12-27 Jennifer Mai Compositions for the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59225122A (en) * 1983-05-23 1984-12-18 Kaken Pharmaceut Co Ltd Remedy and improver for cancerous cachexia
EP0421023B1 (en) * 1989-10-06 1995-03-15 MUCOS EMULSIONSGESELLSCHAFT m.b.H. Catabolic enzymes for the induction of the tumour necrosis factor (TNF)
DE4302060A1 (en) * 1993-01-26 1994-07-28 Mucos Pharma Gmbh & Co Use of bromelain as CD44 surface molecule modifier
GB9313188D0 (en) * 1993-06-25 1993-08-11 Cortecs Ltd Medical use of enzymes

Also Published As

Publication number Publication date
NO965564D0 (en) 1996-12-23
WO1996000082A1 (en) 1996-01-04
FI965204A (en) 1997-02-21
IL114331A0 (en) 1995-10-31
EP0766565A1 (en) 1997-04-09
JPH10502073A (en) 1998-02-24
GB9412711D0 (en) 1994-08-17
CA2193654A1 (en) 1996-01-04
TW403654B (en) 2000-09-01
NO965564L (en) 1997-02-24
ZA955292B (en) 1997-07-28
KR970703784A (en) 1997-08-09
CN1151119A (en) 1997-06-04
FI965204A0 (en) 1996-12-23

Similar Documents

Publication Publication Date Title
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU2749395A (en) Medical use of bromelain
AU3816697A (en) Conservin compositions and therapeutic and diagnostic uses therefor
AU2630295A (en) 2-acylaminopropanol compound and medical composition
AU1115095A (en) Treatment of cellulose
AU4267396A (en) Modified cannula
GB9313188D0 (en) Medical use of enzymes
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU4418096A (en) Diagnosis of pancreatitis
AU2438695A (en) Therapeutic phenoxyalkylpyridazines and intermediates therefor
AU6723294A (en) Use of simmondsine
AU1712395A (en) Medical application of bromelain
AU1181897A (en) Medical use of proteases
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU2154695A (en) Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
AU2992295A (en) Therapeutic method and compounds of use therein
AU5841696A (en) Preparation and use of contrast agents
AU1289695A (en) Human stanniocalcin-alpha
AU7772698A (en) Use of indolamines as antithrombotic medicine
AU8557598A (en) Treatment of fluids
GB9313189D0 (en) Medical use of enzymes
GB9308164D0 (en) Medical use of enzymes
AU6751494A (en) Disposable scalpel
AU1255895A (en) Human mutt2
AUPO511797A0 (en) Therapeutic and diagnostic agents-II

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted